Willemze, R, Jaffe, ES, Burg, G, et al. (2005). WHO-EORTC classification for cutaneous lymphomas. Blood. May 15;105(10):3768–85.Google Scholar

Swerdlow, SH, Campo, E, Harris, NL, et al. (2008). World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press.Google Scholar

Jaffe, ES (1999). Hematopathology: integration of morphologic features and biologic markers for diagnosis. Mod Pathol. Feb;12(2):109–15.Google Scholar

Wood, B (2006). 9-color and 10-color flow cytometry in the clinical laboratory. Arch Pathol Lab Med. May;130(5):680–90.CrossRefGoogle ScholarPubMed

Santucci, M, Biggeri, A, Feller, AC, Massi, D, Burg, G (2000). Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol. Jan;24(1):40–50.Google Scholar

Diamandidou, E, Colome-Grimmer, M, Fayad, L, et al (1998). Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. Blood. 92(4):1150–9.Google Scholar

Massone, C, Kodama, K, Kerl, H, Cerroni, L (2005). Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients. Am J Surg Pathol. Apr;29(4):550–60.CrossRefGoogle Scholar

Cerroni, L, Fink-Puches, R, El-Shabrawi-Caelen, L, et al (1999). Solitary skin lesions with histopathologic features of early mycosis fungoides. Am J Dermatopathol. Dec;21(6):518–24.Google Scholar

Toro, JR, Sander, CA, LeBoit, PE (1997). Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant, precursor, or both? A study by light microscopy and molecular methods. Am J Dermatopathol. Apr;19(2):108–18.CrossRefGoogle ScholarPubMed

Hession, MT, Scheinman, PL (2010). Lymphomatoid allergic contact dermatitis mimicking cutaneous T cell lymphoma. Dermatitis. Jul-Aug;21(4):220.Google Scholar

Rodríguez Pinilla, SM, Roncador, G, Rodríguez-Peralto, JL, et al. (2009). Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol. Jan;33(1):81–90.CrossRefGoogle ScholarPubMed

Grogg, KL, Jung, S, Erickson, LA, McClure, RF, Dogan, A (2008). Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior. Mod Pathol. Jun;21(6):708–15.Google Scholar

Gerami, P, Rosen, S, Kuzel, T, Boone, SL, Guitart, J (2008). Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma. Arch Dermatol. Jun;144(6):738–46.Google Scholar

Muniesa, C, Estrach, T, Pujol, RM, et al (2010). Folliculotropic mycosis fungoides: clinicopathologic features and outcome in a series of 20 cases. J Am Acad Dermatol. Mar;62(3):418–26.CrossRefGoogle Scholar

Mantaka, P, Helsing, P, Gjersvik, P, et al. (2013). Clinical and histopathologic features of folliculotropic mycosis fungoides: a Norwegian patient series. Acta Derm Venereol. May;93(3):325–9.CrossRefGoogle ScholarPubMed

Haghighi, B, Smoller, BR, LeBoit, PE, et al (2000). Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study. Mod Pathol. May;13(5):502–10.CrossRefGoogle ScholarPubMed

Cardoso, J, Duhra, P, Thway, Y, Calonje, E (2012). Lymphomatoid papulosis type D: a newly described variant easily confused with cutaneous aggressive CD8-positive cytotoxic T-cell lymphoma. Am J Dermatopathol. Oct;34(7):762–5.Google Scholar

Jacyk, WK, Grayson, W, Dinkel, JE, Requena, L (2007). Pagetoid reticulosis with CD30 positivity and cytotoxic/suppressor cells. J Cutan Pathol. Aug;34(8):644–7.CrossRefGoogle ScholarPubMed

Mourtzinos, N, Puri, PK, Wang, G, Liu, ML (2010). CD4/CD8 double negative pagetoid reticulosis: a case report and literature review. J Cutan Pathol. Apr;37(4):491–6.Google Scholar

DeGregorio, R, Fenske, NA, Glass, LF (1995). Granulomatous slack skin: a possible precursor of Hodgkin's disease. J Am Acad Dermatol. Dec;33(6):1044–7.CrossRefGoogle ScholarPubMed

Kempf, W, Ostheeren-Michaelis, S, Paulli, M, et al (2008). Cutaneous Lymphoma Histopathology Task Force Group of the European Organization for Research and Treatment of Cancer. Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol. Dec;144(12):1609–17.CrossRefGoogle ScholarPubMed

Ikonomou, IM, Aamot, HV, Heim, S, Fosså, A, Delabie, J (2007). Granulomatous slack skin with a translocation t(3;9)(q12;p24). Am J Surg Pathol. May;31(5):803–6.CrossRefGoogle Scholar

Olsen, E, Vonderheid, E, Pimpinelli, N, et al (2007); ISCL/EORTC. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. Sep 15;110(6):1713–22.Google Scholar

Jawed, SI, Myskowski, PL, Horwitz, S, Moskowitz, A, Querfeld, C (2014). Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. Feb;70(2):205.Google Scholar

Kelemen, K, White, CR, Gatter, K, Braziel, RM, Fan, G (2010). Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides. Am J Clin Pathol, 134:739–48.CrossRefGoogle ScholarPubMed

Jones, D, Dang, NH, Duvic, M, Washington, LT, Huh, YO (2001). Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol, 115:885–92.CrossRefGoogle ScholarPubMed

Diamandidou, E, Colome-Grimmer, M, Fayad, L, et al (1998). Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. Blood. 92(4):1150–9.Google Scholar

Blayney, DW, Jaffe, ES, Fisher, RI, et al. (1983). The human T-cell leukemia/lymphoma virus, lymphoma, lytic bone lesions, and hypercalcemia. Ann Intern Med. Feb;98(2):144–51.Google Scholar

Yamaguchi, T, Ohshima, K, Karube, K, et al. (2005). Clinicopathologic features of cutaneous lesions of adult T-cell leukaemia/lymphoma. Br J Dermatol. Jan;152(1):76–81.Google Scholar

Bittencourt, AL, Barbosa, HS, Vieira, MD, Farré, L (2009). Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histologic and immunohistochemical features of 52 cases. Acta Oncol. 48(4):598–604.Google Scholar

Karube, K, Aoki, R, Sugita, Y, et al. (2008). The relationship of FOXP3 expression and clinicopathologic characteristics in adult T-cell leukemia/lymphoma. Mod Pathol. May;21(5):617–25.Google Scholar

Karube, K, Suzumiya, J, Okamoto, M, et al. (2007). Adult T-cell lymphoma/leukemia with angioimmunoblastic T-cell lymphomalike features: Report of 11 cases. Am J Surg Pathol. Feb;31(2):216–23.Google Scholar

Willemze, R, Jaffe, ES, Burg, G, et al (2005). WHO-EORTC classification for cutaneous lymphomas. Blood. May 15;105(10):3768–85.Google Scholar

Diamandidou, E, Colome-Grimmer, M, Fayad, L, et al (1998). Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. Blood. 92(4):1150–9.CrossRefGoogle ScholarPubMed

Bekkenk, MW, Geelen, FA, van Voorst Vader, PC, et al (2000). Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. Jun 15;95(12):3653–61.Google Scholar

Velusamy, T, Kiel, MJ, Sahasrabuddhe, AA, et al (2014). A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders. Blood. Dec 11;124(25):3768–71.Google ScholarPubMed

Querfeld, C, Khan, I, Mahon, B, et al (2010). Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options. Oncology (Williston Park). Jun;24(7):574–87.Google Scholar

Werner, B, Massone, C, Kerl, H, Cerroni, L (2008). Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin. J Cutan Pathol. Dec;35(12):1100–7.Google Scholar

Kempf, W (2006). CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. J Cutan Pathol. Feb;33 Suppl 1:58–70.CrossRefGoogle ScholarPubMed

Sharma, V, Xu, G, Petronic-Rosic, V, Gerami, P (2007). Clinicopathologic challenge. Regional lymphomatoid papulosis, type A. Int J Dermatol. Sep;46(9):905–9.Google Scholar

Cardoso, J, Duhra, P, Thway, Y, Calonje, E (2012). Lymphomatoid papulosis type D: a newly described variant easily confused with cutaneous aggressive CD8-positive cytotoxic T-cell lymphoma. Am J Dermatopathol. Oct;34(7):762–5.CrossRefGoogle Scholar

Kempf, W, Kazakov, DV, Schärer, L, et al (2013). Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas. Am J Surg Pathol. Jan;37(1):1–13.CrossRefGoogle ScholarPubMed

Plaza, JA, Feldman, AL, Magro, C (2013). Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases. J Cutan Pathol. Feb;40(2):236–47.CrossRefGoogle ScholarPubMed

Kumar, S, Krenacs, L, Medeiros, J, et al (1998). Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Pathol. Apr;29(4):397–403.Google Scholar

Hoque, SR, Child, FJ, Whittaker, SJ, et al (2003). Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol. Mar;148(3):516–25.Google Scholar

Kong, YY, Dai, B, Kong, JC, et al. (2008). Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol. Oct;32(10):1495–502.CrossRefGoogle ScholarPubMed

Willemze, R, Jansen, PM, Cerroni, L, et al (2008). EORTC Cutaneous Lymphoma Group. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. Jan 15;111(2):838–45Google Scholar

Jones, D, Vega, F, Sarris, AH, Medeiros, LJ (2002). CD4-CD8-”Double-negative” cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course. Am J Surg Pathol. Feb;26(2):225–31.Google Scholar

Rodríguez-Pinilla, SM, Ortiz-Romero, PL, Monsalvez, V, et al (2013). TCR-γ expression in primary cutaneous T-cell lymphomas. Am J Surg Pathol. Mar;37(3):375–84.Google Scholar

Berti, E, Cerri, A, Cavicchini, S, et al. (1991). Primary cutaneous gamma/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis. J Invest Dermatol. May;96(5):718–23.CrossRefGoogle ScholarPubMed

Toro, JR, Liewehr, DJ, Pabby, N, et al (2003). Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood. May 1;101(9):3407–12.CrossRefGoogle ScholarPubMed

Willemze, R, Jaffe, ES, Burg, G, et al (2005). WHO-EORTC classification for cutaneous lymphomas. Blood. May 15;105(10):3768–85.Google Scholar

Berti, E, Tomasini, D, Vermeer, MH, et al (1999). Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathologic entity with an aggressive clinical behavior. Am J Pathol. Aug;155(2):483–92.Google Scholar

Robson, A, Assaf, C, Bagot, M, et al (2014). Aggressive Epidermotropic Cutaneous CD8+ Lymphoma: A cutaneous lymphoma with distinct clinical and pathologic features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop. Histopathology. Jan 18. doi: 10.1111/his.12371. [Epub ahead of print].Google Scholar

Marzano, AV, Ghislanzoni, M, Gianelli, U, et al (2005). Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement. Dermatology. 211(3):281–5.Google Scholar

Petrella, T, Maubec, E, Cornillet-Lefebvre, P, et al (2007). Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma? Am J Surg Pathol. Dec;31(12):1887–92.Google Scholar

Beltraminelli, H, Müllegger, R, Cerroni, L (2010). Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma? J Cutan Pathol. Jan;37(1):81–4.Google Scholar

Beltraminelli, H, Leinweber, B, Kerl, H, Cerroni, L (2009). Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Am J Dermatopathol. Jun;31(4):317–22.Google Scholar

Grogg, KL, Jung, S, Erickson, LA, McClure, RF, Dogan, A (2008). Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior. Mod Pathol. Jun;21(6):708–15.CrossRefGoogle ScholarPubMed

Cetinözman, F, Jansen, PM, Willemze, R (2012). Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am J Surg Pathol. Jan;36(1):109–16.Google Scholar

Rodríguez Pinilla, SM, Roncador, G, Rodríguez-Peralto, JL, et al (2009). Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol. Jan;33(1):81–90.Google Scholar

Willemze, R, Jaffe, ES, Burg, G, et al (2005). WHO-EORTC classification for cutaneous lymphomas. Blood. May 15;105(10):3768–85.CrossRefGoogle ScholarPubMed

Swerdlow, SH, Campo, E, Harris, NL, et al (2008). World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press. pp. 285–8.Google Scholar

Takata, K, Hong, ME, Sitthinamsuwan, P, et al (2015). Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia. Am J Surg Pathol. Jan;39(1):1–12.Google Scholar

Choi, YL, Park, JH, Namkung, JH, et al (2009). Extranodal NK/T-cell lymphoma with cutaneous involvement: ‘nasal’ vs. ‘nasal-type’ subgroups: a retrospective study of 18 patients. Br J Dermatol. Feb;160(2):333–7.Google Scholar

Liao, JB, Chuang, SS, Chen, HC, et al (2010). Clinicopathologic analysis of cutaneous lymphoma in Taiwan: a high frequency of extranodal natural killer/T-cell lymphoma, nasal type, with an extremely poor prognosis. Arch Pathol Lab Med. Jul;134(7):996–1002.Google Scholar

Sitthinamsuwan, P, Pongpruttipan, T, Chularojmontri, L,et al. (2010). Extranodal NK/T cell lymphoma, nasal type, presenting with primary cutaneous lesion mimicking granulomatous panniculitis: a case report and review of literature. J Med Assoc Thai. Aug;93(8):1001–7.Google Scholar

Willemze, R, Jaffe, ES, Burg, G, et al. (2005). WHO-EORTC classification for cutaneous lymphomas. Blood. May 15;105(10):3768–85.Google Scholar

Kreisel, F (2011). Case Study Interpretation–Houston: Case 1. Phenytoin-induced ‘‘pseudolymphoma.’’ Cytometry B Clin Cytom. Jul-Aug;80(4):255–7.Google Scholar

Choi, TS, Doh, KS, Kim, SH, et al. (2003). Clinicopathologic and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome. Br J Dermatol. Apr;148(4):730–6.Google Scholar

Harris, DW, Ostlere, L, Buckley, C, et al (1992). Phenytoin-induced pseudolymphoma. A report of a case and review of the literature. Br J Dermatol. Oct;127(4):403–6.Google Scholar

Ramsay, B, Dahl, MC, Malcolm, AJ, Wilson-Jones, E (1990). Acral pseudolymphomatous angiokeratoma of children. Arch Dermatol. Nov;126(11):1524–5.CrossRefGoogle ScholarPubMed

Dayrit, JF, Wang, WL, Goh, SG, Ramdial, PK, Lazar, AJ, Calonje, E (2011). T-cell-rich angiomatoid polypoid pseudolymphoma of the skin: a clinicopathologic study of 17 cases and a proposed nomenclature. J Cutan Pathol. Jun;38(6):475–82.Google Scholar

Kaddu, S, Cerroni, L, Pilatti, A, Soyer, HP, Kerl, H (1994). Acral pseudolymphomatous angiokeratoma. A variant of the cutaneous pseudolymphomas. Am J Dermatopathol. Apr;16(2):130–3.CrossRefGoogle ScholarPubMed

Willemze, R, Jaffe, ES, Burg, G, et al (2005). WHO-EORTC classification for cutaneous lymphomas. Blood. May 15;105(10):3768–85.Google Scholar

Morales, AV, Arber, DA, Seo, K, et al (2008). Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates. Am J Dermatopathol. Oct;30(5):425–30.Google Scholar

Geyer, JT, Ferry, JA, Longtine, JA, et al (2010). Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background. Am J Clin Pathol. Jan;133(1):59–69.Google Scholar

Ritter, JH, Wick, MR, Adesokan, PN, et al (1997). Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement. Am J Clin Pathol. Jul;108(1):60–8.Google Scholar

de Leval, L, Harris, NL, Longtine, J, Ferry, JA, Duncan, LM (2001). Cutaneous B-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am J Surg Pathol. Jun;25(6):732–41.Google Scholar

Willemze, R, Jaffe, ES, Burg, G, et al (2005). WHO-EORTC classification for cutaneous lymphomas. Blood. May 15;105(10):3768–85.Google Scholar

Santucci, M, Pimpinelli, N, Arganini, L (1991). Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases. Cancer. May 1;67(9):2311–26.Google Scholar

Morales, AV, Arber, DA, Seo, K, et al (2008). Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates. Am J Dermatopathol. Oct;30(5):425–30.CrossRefGoogle ScholarPubMed

Kempf, W, Kazakov, DV, Rütten, A, et al (2014). Primary cutaneous follicle center lymphoma with diffuse CD30 expression: a report of 4 cases of a rare variant. J Am Acad Dermatol. Sep;71(3):548–54.Google Scholar

Ritter, JH, Wick, MR, Adesokan, PN, et al. (1997). Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement. Am J Clin Pathol. Jul;108(1):60–8.Google Scholar

de Leval, L, Harris, NL, Longtine, J, Ferry, JA, Duncan, LM (2001). Cutaneous B-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am J Surg Pathol. Jun;25(6):732–41.CrossRefGoogle ScholarPubMed

Abdul-Wahab, A, Tang, SY, Robson, A, et al (2014). Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis. J Am Acad Dermatol. Jun;70(6):1010–20.Google Scholar

Demirkesen, C, Tüzüner, N, Esen, T, Lebe, B, Ozkal, S (2011). The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma. Leuk Res. Sep;35(9):1269–72.Google Scholar

Clarke, LE, Bayerl, MG, Ehmann, WC, Helm, KF (2003). Cutaneous B-cell lymphoma with loss of CD20 immunoreactivity after rituximab therapy. J Cutan Pathol. Aug;30(7):459–62.Google Scholar

Willemze, R, Meijer, CJ, Sentis, HJ, et al (1987). Primary cutaneous large cell lymphomas of follicular center cell origin. A clinical follow-up study of nineteen patients. J Am Acad Dermatol. Mar;16(3 Pt 1):518–26.Google Scholar

Willemze, R, Jaffe, ES, Burg, G, et al (2005). WHO-EORTC classification for cutaneous lymphomas. Blood. May 15;105(10):3768–85.Google Scholar

Vermeer, MH, Geelen, FA, van Haselen, CW, et al (1996). Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. Arch Dermatol. Nov;132(11):1304–8.CrossRefGoogle ScholarPubMed

Plaza, JA, Kacerovska, D, Sangueza, M, et al (2014). Can cutaneous low-grade B-cell lymphoma transform into primary cutaneous diffuse large B-cell lymphoma? An immunohistochemical study of 82 cases. Am J Dermatopathol. Jun;36(6):478–82.CrossRefGoogle ScholarPubMed

Wiesner, T, Streubel, B, Huber, D, et al (2005). Genetic aberrations in primary cutaneous large B-cell lymphoma: a fluorescence in situ hybridization study of 25 cases. Am J Surg Pathol. May;29(5):666–73.Google Scholar

Hallermann, C, Kaune, KM, Gesk, S, et al (2004). Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. J Invest Dermatol. Jul;123(1):213–19.Google Scholar

Pham-Ledard, A, Prochazkova-Carlotti, M, Andrique, L, et al (2014). Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma. Mod Pathol. Mar;27(3):402–11.Google Scholar

Hristov, AC (2012). Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations. Arch Pathol Lab Med. Aug;136(8):876–81.Google Scholar

Clarke, LE, Bayerl, MG, Ehmann, WC, Helm, KF (2003). Cutaneous B-cell lymphoma with loss of CD20 immunoreactivity after rituximab therapy. J Cutan Pathol. Aug;30(7):459–62.Google Scholar

Harris, NL, Jaffe, ES, Stein, H, et al (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. Sep 1;84(5):1361–92.Google Scholar

Stein, H, Warnke, RA, Chan, WC, et al (2008). Diffuse large B-cell lymphoma, not otherwise specified. Swerdlow, SH, Campo, E, Harris, NL et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th Edn. France: IARC Lyon, pp. 233–7.Google Scholar

Lu, CS, Chen, JH, Huang, TC, et al (2015). Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era. Leuk Lymphoma. Jan 14:1–9.Google Scholar

Ferreri, AJ, Campo, E, Seymour, JF, et al (2004). International Extranodal Lymphoma Study Group (IELSG). Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol. Oct;127(2):173–83.Google Scholar

Oyama, T, Yamamoto, K, Asano, N, et al (2007). Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res. Sep 1;13(17):5124–32.Google Scholar

Nakamura, S, Jaffe, E, Swerdlow, SH (2008). EBV positive diffuse large B-cell lymphoma of the elderly. In Swerdlow, SH, Campo, E, Harris, NL et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th Edn. France: IARC Lyon, pp. 233–7.Google Scholar

Willemze, R, Jaffe, ES, Burg, G, et al (2005). WHO-EORTC classification for cutaneous lymphomas. Blood. May 15;105(10):3768–85.CrossRefGoogle ScholarPubMed

Santucci, M, Pimpinelli, N, Arganini, L (1991). Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases. Cancer. May 1;67(9):2311–26.Google Scholar

Robak, E, Robak, T (2007). Skin lesions in chronic lymphocytic leukemia. Leuk Lymphoma. May;48(5):855–65.Google Scholar

Cerroni, L, Zenahlik, P, Höfler, G (1996). Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia: a clinicopathologic and prognostic study of 42 patients. Am J Surg Pathol. Aug;20(8):1000–10.Google Scholar

Duong, T, Grange, F, Auffret, N, et al. (2010). Cutaneous Richter's syndrome, prognosis, and clinical, histologic and immunohistologic patterns: report of four cases and review of the literature. Dermatology. 220(3):226–33CrossRefGoogle ScholarPubMed

Borowitz, MJ, Chan, JKC (2008). B lymphoblastic leukaemia/lymphoma, not otherwise specified. In Swerdlow, SH, Campo, E, Harris, NL et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th Edn. France: IARC Lyon, pp. 168–70.Google Scholar

Sander, CA, Jaffe, ES, Gebhardt, FC, Yano, T, Medeiros, LJ (1992). Mediastinal lymphoblastic lymphoma with an immature B-cell immunophenotype. Am J Surg Pathol. Mar;16(3):300–5.CrossRefGoogle ScholarPubMed

Lin, P, Jones, D, Dorfman, DM, Medeiros, LJ (2000). Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol. Nov;24(11):1480–90.Google Scholar

Vezzoli, P, Novara, F, Fanoni, D, et al (2012). Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature. Leuk Lymphoma. Oct;53(10):1978–87.Google Scholar

Maitra, A, McKenna, RW, Weinberg, AG, Schneider, NR, Kroft, SH (2001). Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature. Am J Clin Pathol. Jun;115(6):868–75.Google Scholar

Pileri, SA, Orazi, A, Falini, B (2008). Myeloid sarcoma. In Swerdlow, SH, Campo, E, Harris, NL et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th Edn. France: IARC Lyon, pp. 140–141.Google Scholar

Pileri, SA, Ascani, S, Cox, MC, et al (2007). Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. Feb;21(2):340–50.Google Scholar

Alexiev, BA, Wang, W, Ning, Y, et al (2007). Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study. Diagn Pathol. Oct 31;2:42.Google Scholar

Raphael, J, Valent, A, Hanna, C, et al (2014). Myeloid sarcoma of the nasopharynx mimicking an aggressive lymphoma. Head Neck Pathol. Jun;8(2):234–8.Google Scholar

Ojha, SS, Kothari, KS, Naik, LP, Fernandes, GC, Rangwala, S, Agnihotri, MA (2012). Dysplastic megakaryocytes and eosinophilic precursors in the diagnosis of myeloid sarcoma on lymph node fine-needle aspiration cytology: a case series. Acta Cytol. 56(3):325–9.Google Scholar

Sano, F, Tasaka, T, Nishimura, H, et al (2008). A peculiar case of acute myeloid leukemia mimicking plasmacytoid dendritic precursor cell leukemia. J Clin Exp Hematop. Nov;48(2):65–9.Google Scholar

Facchetti, F, Jones, DM, Petrella, T (2008). Blastic plasmacytoid dendritic cell neoplasm. In Swerdlow, SH, Campo, E, Harris, NL et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th Edn. France: IARC Lyon, pp. 145–7.Google Scholar

Paluri, R, Nabell, L, Borak, S, Peker, D (2014). Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review. Hematol Oncol. May 21, doi: 10.1002/hon.2147. [Epub ahead of print].CrossRefGoogle Scholar

Petrella, T, Bagot, M, Willemze, R, et al (2005). Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. May;123(5):662–75.Google Scholar

Jacob, MC, Chaperot, L, Mossuz, P, et al (2003). CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica. Aug;88(8):941–55.Google Scholar

Jegalian, AG, Facchetti, F, Jaffe, ES (2009). Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol. Nov;16(6):392–404.Google Scholar

Herling, M, Jones, D (2007). CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol. May;127(5):687–700.Google Scholar

Jardin, F, Ruminy, P, Parmentier, F, et al (2011). TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm. Br J Haematol. May;153(3):413–16.Google Scholar

Horny, H, Metcalfe, DD, Bennett, JM, et al (2008). Mastocytosis. In Swerdlow, SH, Campo, E, Harris, NL et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th Edn. France: IARC Lyon, pp. 54–63.Google Scholar

Valent, P, Akin, C, Escribano, L et al (2007). Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest. Jun;37(6):435–53.Google Scholar

Kiszewski, AE, Alvarez-Mendoza, A, Ríos-Barrera, VA, Hernández-Pando, R, Ruiz-Maldonado, R (2007). Mastocytosis in children: clinicopathologic study based on 35 cases. Histol Histopathol. May;22(5):535–9.Google Scholar

Wolff, K, Komar, M, Petzelbauer, P (2001). Clinical and histopathologic aspects of cutaneous mastocytosis. Leuk Res. Jul;25(7):519–28.CrossRefGoogle ScholarPubMed

Lanternier, F, Cohen-Akenine, A, Palmerini, F, et al (2008). AFIRMM network. Phenotypic and genotypic characteristics of mastocytosis according to the age of onset. PLoS One. Apr 9;3(4):e1906.Google Scholar

Berezowska, S, Flaig, MJ, Ruëff, F, et al (2014). Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis. Mod Pathol. Jan;27(1):19–29.CrossRefGoogle ScholarPubMed

Jaffe, R, Weiss, LM, Facchetti, F (2008). Tumors derived from Langerhans cells. In Swerdlow, SH, Campo, E, Harris, NL et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th Edn. France: IARC Lyon, 358–60.Google Scholar

Favara, BE, Feller, AC, Pauli, M, et al (1997). Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol. Sep;29(3):157–66.Google Scholar

Querings, K, Starz, H, Balda, BR (2006). Clinical spectrum of cutaneous Langerhans’ cell histiocytosis mimicking various diseases. Acta Derm Venereol. 86(1):39–43.CrossRefGoogle ScholarPubMed

Sholl, LM, Hornick, JL, Pinkus, JL, Pinkus, GS, Padera, RF (2007). Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases. Am J Surg Pathol. Jun;31(6):947–52.CrossRefGoogle ScholarPubMed

Badalian-Very, G, Vergilio, JA, Degar, BA, et al (2010). Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. Sep 16;116(11):1919–23.Google Scholar

Lau, SK, Chu, PG, Weiss, LM (2008). Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol. Apr;32(4):615–19.CrossRefGoogle ScholarPubMed

Freyer, DR, Kennedy, R, Bostrom, BC, Kohut, G, Dehner, LP (1996). Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr. Aug;129(2):227–37.Google Scholar

Dehner, LP (2003). Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol. May;27(5):579–93.Google Scholar

Fenot, M, Stalder, JF, Barbarot, S (2014). Juvenile xanthogranulomas are highly prevalent but transient in young children with neurofibromatosis type 1. J Am Acad Dermatol. Aug;71(2):389–90.Google Scholar

Price, HN, Zaenglein, AL (2007). Diagnosis and management of benign lumps and bumps in childhood. Curr Opin Pediatr. Aug;19(4):420–4.Google Scholar

Cham, E, Siegel, D, Ruben, BS (2010). Cutaneous xanthogranulomas, hepatosplenomegaly, anemia, and thrombocytopenia as presenting signs of juvenile myelomonocytic leukemia. Am J Clin Dermatol. 11(1):67–71.Google Scholar

Barrow, MV, Holubar, K (1969). Multicentric reticulohistiocytosis: a review of 33 patients. Medicine 48(4): 287–305.Google Scholar

Tajirian, AL, Malik, MK, Robinson-Bostom, L, Lally, EV (2006). Multicentric reticulohistiocytosis. Clin Dermatol. Nov–Dec;24(6):486–92.Google Scholar

Mun, JH, Ko, HC, Kim, MB (2012). Multicentric reticulohistiocytosis masquerading as dermatomyositis: similar and different features. J Dermatol. Jan;39(1):104–7.CrossRefGoogle ScholarPubMed

Munoz-Santos, C, Sàbat, M, Sáez, A, Gratacós, J, Luelmo, J. (2007). Multicentric reticulohistiocytosis-mimicking dermatomyositis. Dermatology 214(3):268–71.CrossRefGoogle ScholarPubMed

Ortiz-Hidalgo, C, Cuesta-Mejías, TC, Ochoa-Ochoa, C, Valenzuela-Espinosa, A, Toussaint-Caire, S (2003). [Rosai-Dorfman disease limited to the skin. Four case reports]. Gac Med Mex. Jan–Feb;139(1):1–6.Google Scholar

Eisen, RN, Buckley, PJ, Rosai, J (1990). Immunophenotypic characterization of sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease). Semin Diagn Pathol. Feb;7(1):74–82.Google Scholar

Foucar, E, Rosai, J, Dorfman, RF (1984). Sinus histiocytosis with massive lymphadenopathy. An analysis of 14 deaths occurring in a patient registry. Cancer. Nov 1;54(9):1834–40.Google Scholar

O'Malley, DP, Duong, A, Barry, TS, et al (2010). Co-occurrence of Langerhans cell histiocytosis and Rosai–Dorfman disease: possible relationship of two histiocytic disorders in rare cases. Mod Pathol. Dec;23(12):1616–23.Google Scholar

Wang, RF, Han, W, Qi, L, Shan, LH, Wang, ZC, Wang, LF (2015). Extranodal follicular dendritic cell sarcoma: A clinicopathologic report of four cases and a literature review. Oncol Lett. Jan;9(1):391–8.Google Scholar

Kazakov, DV, Morrisson, C, Plaza, JA, Michal, M, Suster, S (2005). Sarcoma arising in hyaline-vascular castleman disease of skin and subcutis. Am J Dermatopathol. Aug;27(4):327–32.Google Scholar

Orii, T, Takeda, H, Kawata, S, Maeda, K, Yamakawa, M (2010) Differential immunophenotypic analysis of dendritic cell tumors. J Clin Pathol. Jun;63(6):497–503Google Scholar

Pillay, K, Solomon, R, Daubenton, JD, Sinclair-Smith, CC (2004). Interdigitating dendritic cell sarcoma: a report of four paediatric cases and review of the literature. Histopathology. Mar;44(3):283–91.Google Scholar

Vasef, MA, Zaatari, GS, Chan, WC, Sun, NC, Weiss, LM, Brynes, RK (1995). Dendritic cell tumors associated with low-grade B-cell malignancies. Report of three cases. Am J Clin Pathol. Dec;104(6):696–701.Google Scholar

Pileri, SA, Grogan, TM, Harris, NL, et al (2002). Tumors of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. Jul;41(1):1–29.Google Scholar

Nakamura, S, Hara, K, Suchi, T, et al (1988). Interdigitating cell sarcoma. A morphologic, immunohistologic, and enzyme-histochemical study. Cancer. Feb 1;61(3):562–8.Google Scholar

Weiss, LM, Chan, JKC, Fletcher, CDM (2008). Other rare dendritic cell tumors. In Swerdlow, SH, Campo, E, Harris, NL et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th Edn. France: IARC Lyon, 365.Google Scholar

Rezk, SA, Spagnolo, DV, Brynes, RK, Weiss, LM (2008). Indeterminate cell tumor: a rare dendritic neoplasm. Am J Surg Pathol. Dec;32(12):1868–76.Google Scholar